Recent Quotes (30 days)

You have no recent quotes
chg | %

Luminor Medical Technologies Inc  

(Public, CVE:LMT)   Watch this stock  
Find more results for CVE:MOM
0.175
0.000 (0.00%)
Jun 28 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.17 - 0.35
Open     -
Vol / Avg. 410.00/4,158.00
Mkt cap 343,787.00
P/E     -
Div/yield     -
EPS -1.60
Shares 2.02M
Beta 0.20
Inst. own     -

Key stats and ratios

Q1 (Feb '16) 2015
Net profit margin - -35914.64%
Operating margin - -30978.80%
EBITD margin - -19607.43%
Return on average assets -255.34% -220.52%
Return on average equity - -
CDP Score - -

Address

6-1250 Waverley St
WINNIPEG, MB R3T 6C6
Canada
+1-204-4531408 (Phone)
+1-204-4531546 (Fax)

Website links

Description

Luminor Medical Technologies Inc., formerly Miraculins Inc., is a Canada-based medical diagnostic company. The Company is focused on acquiring, developing and commercializing non-invasive technologies for various clinical needs. It offers Scout DS device, which is a clinical tool to assist in the identification of both pre-diabetes and type 2 diabetes, and is a non-invasive testing system that provides a method for measuring pre-diabetes/type 2 diabetes related biomarkers in the skin. The Company is in various stages of development of diagnostic and risk assessment products.

Officers and directors

Harry J F Bloomfield Independent Chairman of the Board
Age: 70
Christian Sauvageau President, Chief Executive Officer, Director
Christopher A. Carmichael CPA Chief Financial Officer
Ashwath Mehra Director